Archived Newsletters

1. 11.23.22 -- Using An Integrated Approach For Technology Transfers And Scale-Up 11/23/2022

   11/23/22 Outsourced Pharma Newsletter

2. 11.23.22 -- Merck, Medimmune, Keytruda: An Ultimate Outsourcing Story 11/23/2022
   11/23/22 Outsourced Pharma Newsletter
3. 11.23.22 -- Challenges & Solutions In Cell & Gene Therapy Manufacturing 11/23/2022
   11/23/22 Outsourced Pharma Newsletter
4. 11.23.22 -- Merck, Medimmune, And Keytruda: An Ultimate Outsourcing Story 11/23/2022
   11/23/22 Outsourced Pharma Newsletter
5. 11.23.22 -- Merck, Medimmune, And Keytruda: An Ultimate Outsourcing Story 11/23/2022
   11/23/22 Outsourced Pharma Newsletter
6. 11.22.22 -- Complex Injectables Development & Manufacturing: Considerations And Choosing A CDMO 11/22/2022

   11/22/22 Outsourced Pharma Newsletter

7. 11.22.22 -- Leveraging Advanced Technologies To Accelerate Pharma Development 11/22/2022

   11/22/22 Outsourced Pharma Newsletter

8. 11.21.22 -- AAV Manufacturing: Dual-Plasmid Transfection System Improves Titer & Product Quality 11/21/2022

   11/21/22 Outsourced Pharma Newsletter

9. 11.21.22 -- The "Outsourcing Master Class": 10 Modules For Success 11/21/2022
   11/21/22 Outsourced Pharma Newsletter
10. 11.21.22 -- Tips For Your Virtual Meetings With FDA 11/21/2022
    11/21/22 Outsourced Pharma Newsletter